| __timestamp | Johnson & Johnson | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 8393000000 |
| Thursday, January 1, 2015 | 9046000000 | 7690000000 |
| Friday, January 1, 2016 | 9095000000 | 7872000000 |
| Sunday, January 1, 2017 | 10554000000 | 7657000000 |
| Monday, January 1, 2018 | 10775000000 | 8006000000 |
| Tuesday, January 1, 2019 | 11355000000 | 8650000000 |
| Wednesday, January 1, 2020 | 12340000000 | 9405000000 |
| Friday, January 1, 2021 | 14277000000 | 13829000000 |
| Saturday, January 1, 2022 | 14135000000 | 11428000000 |
| Sunday, January 1, 2023 | 15048000000 | 10679000000 |
| Monday, January 1, 2024 | 17232000000 | 10930000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) investment is a key driver of innovation and growth. Over the past decade, Johnson & Johnson and Pfizer Inc. have been at the forefront of this race, consistently channeling significant resources into R&D. From 2014 to 2023, Johnson & Johnson's R&D expenses surged by approximately 77%, peaking at $15 billion in 2023. Meanwhile, Pfizer Inc. demonstrated a robust 27% increase, reaching nearly $11 billion in the same year.
This trend underscores the strategic importance both companies place on innovation to maintain their competitive edge. Notably, 2021 marked a pivotal year, with Pfizer's R&D spending reaching its zenith, likely driven by the global demand for COVID-19 vaccines. As these giants continue to invest heavily in R&D, the future of healthcare innovation looks promising.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Johnson & Johnson or Exelixis, Inc.: Who Invests More in Innovation?
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Johnson & Johnson or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.